Zynex, Inc. (NASDAQ: ZYXI) (“Zynex”, “ZMS”, “we” or the “Company”), an innovative medical technology company specializing in the…
Category: Insights
Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences
Precision for Medicine, a leading next-generation provider of drug development and commercialization services, today announced the…
Precision Biologics to Announce Development of New Monoclonal Antibody (mAb) PB-223 at SITC, Houston, TX, November 7-8, 2024
Precision Biologics, Inc. reports that affinity maturation and characterization of its novel anti-core 2 O-glycan monoclonal antibody…
Econologics Financial Advisors Announces Specialized Financial Services to Practice Associates
Econologics Financial Advisors (EFA), a trusted provider of personal financial planning services for healthcare practice owners,…
Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and…
ADVANCED NANOTHERAPIES ANNOUNCES POSITIVE RESULTS IN ITS FIRST-IN-HUMAN TRIAL AND PLANS FOR U.S. EARLY FEASIBILITY STUDY FOR SIRPLUX™ DUO DRUG-COATED BALLOON
Advanced NanoTherapies (ANT), a clinical-stage medical device company committed to solving the most significant challenges in vascular…
Patient Files Civil Suit Against Erlanger Health and Dr. Thomas V. Clayton Alleging Sexual Abuse and Negligence
Andreozzi + Foote, a leading law firm specializing in the representation of victims of institutional abuse,…
FLORIDA SOUTHERN COLLEGE RECEIVES SACSCOC APPROVAL FOR MASTER OF SCIENCE IN PSYCHIATRIC-MENTAL HEALTH NURSE PRACTITIONER PROGRAM FOR JANUARY 2025
The Ann Blanton Edwards School of Nursing and Health Sciences at Florida Southern College has received approval from…
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 23, 2024, the company approved non-statutory stock options…
Centering Healthcare Institute Receives $7.6 Million Investment To Scale and Amplify Impact of Proven Healthcare Model
Centering Healthcare Institute (CHI) is pleased to announce the receipt of a $7.6 million investment from The Studio…